Literature DB >> 10986400

Synthesis of high avidity antibody fragments (scFv multimers) for cancer imaging.

B E Power1, P J Hudson.   

Abstract

Multivalent antibody fragments (scFv dimers, trimers and tetramers) provide high avidity and ideal pharmacokinetics for tumour targeting applications. This protocol describes our optimised protocol for high-level bacterial synthesis of soluble antibody scFv fragments, as either monomers or multimers, using the heat-inducible bacterial expression vector pPOW3. Our protocol is rapid, which minimizes protein degradation, and utilises inexpensive reagents for cost-effective product synthesis. The strong, temperature-regulated promoters in pPOW3 provide efficient production of either monomeric or multimeric single-chain antibody fragments as dictated by the gene construct design.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10986400     DOI: 10.1016/s0022-1759(00)00201-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  7 in total

1.  Recombinant single-chain Fv antibodies that recognize the p25 protein of the Maedi-Visna virus.

Authors:  V Celer; D Blazek; I Navrátilová; P Skládal; B Blacklaws; R Bujdoso
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

2.  Noncovalent scFv multimers of tumor-targeting anti-Lewis(y) hu3S193 humanized antibody.

Authors:  Barbara E Power; Larissa Doughty; Deborah R Shapira; John E Burns; Ann M Bayly; Joanne M Caine; Zhanqi Liu; Andrew M Scott; Peter J Hudson; Alexander A Kortt
Journal:  Protein Sci       Date:  2003-04       Impact factor: 6.725

3.  Construction, expression and tumor targeting of a single-chain Fv against human colorectal carcinoma.

Authors:  Jin Fang; Hong-Bin Jin; Jin-Dan Song
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

4.  Pharmacokinetics and biodistribution of 177Lu-labeled multivalent single-chain Fv construct of the pancarcinoma monoclonal antibody CC49.

Authors:  Subhash C Chauhan; Maneesh Jain; Erik D Moore; Uwe A Wittel; Jing Li; Peter R Gwilt; David Colcher; Surinder K Batra
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-10-02       Impact factor: 9.236

5.  Tumor targeting by a multivalent single-chain Fv (scFv) anti-Lewis Y antibody construct.

Authors:  Marcus P Kelly; F-T Lee; Kiki Tahtis; Barbara E Power; Fiona E Smyth; Martin W Brechbiel; Peter J Hudson; Andrew M Scott
Journal:  Cancer Biother Radiopharm       Date:  2008-08       Impact factor: 3.099

6.  Computer-based Engineering of Thermostabilized Antibody Fragments.

Authors:  Jiwon Lee; Bryan S Der; Christos S Karamitros; Wenzong Li; Nicholas M Marshall; Oana I Lungu; Aleksandr E Miklos; Jianqing Xu; Tae Hyun Kang; Chang-Han Lee; Bing Tan; Randall A Hughes; Sang Taek Jung; Gregory C Ippolito; Jeffrey J Gray; Yan Zhang; Brian Kuhlman; George Georgiou; Andrew D Ellington
Journal:  AIChE J       Date:  2019-11-19       Impact factor: 3.993

Review 7.  Design and Production of Bispecific Antibodies.

Authors:  Qiong Wang; Yiqun Chen; Jaeyoung Park; Xiao Liu; Yifeng Hu; Tiexin Wang; Kevin McFarland; Michael J Betenbaugh
Journal:  Antibodies (Basel)       Date:  2019-08-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.